Institute of Nutrition of Central America and Panama Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00283660
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Institute of Nutrition of Central America and Panama | Institute of Nutrition of Central America and Panama (INCAP)

Active Ingredients

Drugs in Phase 3 Trials (2)

azithromycin (zithromax) (1 trial)

iron (1 trial)

Drugs in Other Trials (1)

zinc dichloride (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3